A detailed history of City Center Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, City Center Advisors, LLC holds 536 shares of LLY stock, worth $411,519. This represents 0.53% of its overall portfolio holdings.

Number of Shares
536
Previous 535 0.19%
Holding current value
$411,519
Previous $416 Million 14.09%
% of portfolio
0.53%
Previous 0.49%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$772.14 - $960.02 $772 - $960
1 Added 0.19%
536 $475 Million
Q1 2024

Jul 23, 2024

BUY
$592.2 - $792.28 $316,827 - $423,869
535 New
535 $416 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track City Center Advisors, LLC Portfolio

Follow City Center Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of City Center Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on City Center Advisors, LLC with notifications on news.